MetaCap

Blue Water Acquisition III Unit. (BLUWU) vs Liminatus Pharma (LIMN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Relative performance

BLUWU-0.76%LIMN-24.23%
+1%-12%-26%
Oct 7, 20261 yearNov 11, 2026
BLUWU-0.76%LIMN-20.48%
+1%-13%-26%
Oct 5, 20265 yearsNov 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BLUWU versus LIMN key metrics
MetricBLUWULIMN
Share price$10.42$2.51
Market cap—$3.37M
1-day change0.00%-10.68%
YTD return-1.23%—
EPS (TTM)—$-23.50
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$4.67M$-10.21M
52-week high$12.85$141.50
52-week low$0.00$2.40
Distance from 52-week high-18.91%-98.23%
Average volume4530.88K
Shares outstanding—1.34M
Employees—1
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Blue Water Acquisition III Unit.

BLUWU stock →

Blue Water Acquisition Corp. III does not have significant operations.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances)

About Liminatus Pharma

LIMN stock →

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 1 employees

BLUWU vs LIMN FAQ

Are Blue Water Acquisition III Unit. and Liminatus Pharma in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons